International Medical News Group has been acquired by Quadrant HealthCom Inc.
Reed Elsevier Group Plc has sold International Medical News Group (IMNG), the leading provider of medical news, to Quadrant HealthCom Inc. (Quadrant), which is owned by the investment firm M.E. Zukerman, forming Frontline Medical Communications, under which the two entities will operate their individual brands. Combined, company revenues are now over US$60 million. Financial terms of this transaction have not been disclosed.
IMNG President and CEO, Alan Imhoff, will remain in his role, joining Quadrant President and CEO, Marcy Holeton, Custom Solutions President, JoAnn Wahl and CFO, Doug Grose, in a combined "Office of the President" which will oversee company operations. Stephen Stoneburn will become chairman of Frontline Medical Communications.
New Jersey-based Quadrant is a multimedia communications company specializing in the healthcare market, publishing 13 medical journals, 24 websites and 10 events. In late 2009, the company bought four medical journals in the Dowden Professional Publications group from Lebhar-Friedman. As a result of this acquisition, Quadrant greatly expands its brands and audience reach. Frontline Medical Communications will produce 29 publications in 17 market segments. The group will also publish 125 e-newsletters, 35 websites and 14 live events.
Reed Elsevier Group Plc operates as a professional information solutions provider in the UK and internationally.
Oaklins' media specialist team in New York advised the seller in this transaction.
Talk to the deal team
Roland DeSilva
Oaklins DeSilva+Phillips
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more